Gene Query: ZNF430

Dataset Description Geneva Score
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 21.71
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 21.71
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 21.49
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 19.45
Tracking of dCas9-methyltransferase footprints 10.16
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 9.22
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 9.11
RNA-sequencing of formalin fixed human primary melanoma tissue 8.68
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.95
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 7.95
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.79
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.62
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 7.61
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.39
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.39
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 7.36
T47D RNA-seq and ChrRNA-seq data 7.07
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.07
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 7.03
CircRNAome diversity in human mature B-cells, T-cells and monocytes 6.73
UV_24h_GRO-Seq 6.72
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.56
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.56
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 6.44
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.27
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.19
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 5.79
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.76
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 5.72
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 5.58
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.54
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 5.43
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 5.36
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.35
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 5.32
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 5.32
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.19
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.16
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.15
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 5.14
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 5.09
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 5.04
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 4.92
CROP-Seq in Primary Human T Cells 4.56
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 4.27
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.25
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.14
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.14
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.06
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 4.01
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.99
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 3.99
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.96
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.91
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.91
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.83
Human cell line and subcutaneous tumor 3.83
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 3.82
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.73
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.69
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 3.66
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.66
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.63
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 3.61
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 3.61
RNA-seq of YB5 cells treated with Proscillaridin A 3.51
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 3.5
Effect of disulfiram treatment on pediatric high grade glioma 3.49
The Human Testis Cell Atlas via Single-cell RNA-seq 3.48
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.46
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.46
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 3.45
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 3.38
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.38
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.38
Targeted enhancer activation by a subunit of the integrator complex 3.35
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.35
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.35
Transcriptional profile in human S. haematobium infection 3.35
ML29755 RNA-seq data 3.34
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 3.33
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.33
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.33
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 3.3
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 3.3
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.26
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 3.23
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.21
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.16
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.15
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.15
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 3.15
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.12
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.12
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.11
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.07
Human neutrophil genome during PMA- and E. coli encounter-induced activation 3.0
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 3.0
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 2.99
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.99
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.99
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 2.98
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 2.91
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 2.91
Effect of PRDM11 depletion in U2932 cells 2.9
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.85
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.85
Gene expression signatures of innate lymphoid cells from human blood 2.84
SRSF2 mutations impair hematopoiesis and alter exon recognition 2.84
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.83
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 2.8
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 2.77
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 2.76
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.76
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.75
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.73
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.73
Recovery and analysis of nascent RNA 2.73
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.71
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.7
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.67
R430: A potent inbibitor of DNA and RNA viruses 2.65
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.65
Capturing the Interactome of Newly Transcribed RNA 2.65
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.63
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 2.61
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.61
Single cell transcriptome of peritoneal cells 2.61
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.59
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.57
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 2.51
Identification of renal resident macrophages across species 2.5
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 2.5
Identification of global regulators of T-helper cell lineage specification 2.5
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.48
RNA m5C Methylation in breast cancer using MeRIP-Seq 2.47
Gene expression profiling of leukemia cells following asparagine depletion 2.47
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.46
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.46
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.46
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.45
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.45
mRNA expression profile of Lymphocytes 2.44
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.44
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.44
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.41
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.4
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.39
RNA-Seq from human ILC transitional populations 2.36
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.36
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.35
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.33
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.33
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 2.33
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 2.33
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.29
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.29
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 2.26
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 2.25
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.25
Targeting MTHFD2 in Acute Myeloid Leukemia 2.25
The evolution of N6-methyladenosine in primates 2.24
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.23
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 2.21
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.21
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.2
DRB/GRO-Seq -/+ UV 2.2
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.19
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.19
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.19
Reassessment of Exosome Composition 2.18
Direct Isolation and Characterization of Human Nephron Progenitors. 2.16
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.16
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.16
Expression and functions of long noncoding RNAs during human T helper cell differentiation 2.15
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 2.15
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 2.15
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 2.13
Expression by CD133+ cells isolated from the adult human exocrine pancreas 2.11
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 2.11
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.11
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.1
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.07
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.05
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 2.04
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 2.03
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 2.0
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.97
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 1.96
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 1.95
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.94
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 1.94
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.93
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.93
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.92
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.91
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.89
MYC dependent mRNA translation shapes gene expression and cell biology 1.88
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.88
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.87
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.87
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.85
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.85
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 1.84
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 1.82
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.81
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 1.8
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 1.78
Unique features and clinical importance of acute alloreactive immune responses 1.77
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.76
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 1.75
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.74
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.74
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.73
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.73
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.73
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.73
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.72
Single-cell analysis of adult human ovary using 10X genomics 1.72
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.68
TT-Seq captures the human transient transcriptome 1.68
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.68
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.66
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.65
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.65
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.64
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 1.64
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.62
Peptidomimetic blockade of MYB in acute myeloid leukemia 1.61
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 1.61
Transcriptomes in healthy and CHB fetal hearts 1.6
The Genomic Landscape of Atypical Fibroxanthoma 1.6
Comparison of microRNA Profiling Platforms (HTS) 1.6
Comparison of microRNA Profiling Platforms 1.6
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 1.59
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.58
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.57
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.56
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.56
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.54
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.54
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 1.53
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.53
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.53
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.5
Landscape and variation of RNA secondary structure across the human transcriptome 1.5
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.48
SRSF1 role in cellular gene expression and splicing 1.47
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.47
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.47
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.47
RNA sequencing of primary human platelets and in vitro cell lines 1.46
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.45
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 1.45
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 1.45
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.43
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.4
Single-Cell Genotyping of Transcriptomes 1.39
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.39
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.39
RNA polymerase in pre-B-ALL cell lines 1.37
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 1.37
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.36
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 1.36
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.36
Total RNA-seq in ALL-SIL upon JQ1 inhibition 1.35
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.34
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.31
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 1.3
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.3
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.3
Expression patterns in chronic thromboembolic pulmonary hypertension 1.29
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.26
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.24
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 1.24
Human Treg NaCl stimulation 1.23
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 1.23
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.22
Transcriptome Profiling of Human Primary Monocytes 1.22
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.2
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.2
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.17
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 1.17
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 1.16
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.15
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 1.12
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.12
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.1
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.09
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 1.08
Transcriptional profiling of microglia; current state of the art and future perspectives 1.08
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.08
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.06
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.06
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.06
Metastasis in triple-negative breast cancer 1.06
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.04
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.02
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.01
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 1.01
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 1.0
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.99
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.97
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.97
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.97
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.97
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 0.96
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.95
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.94
Transcription elongation regulates genome 3D structure 0.94
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.92
Tracking distinct RNA populations using efficient and reversible covalent chemistry 0.92
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.92
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.92
Functional significance of the HIV-1 Tat signature amino acid residues 0.9
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 0.9
SLAM-seq for K562 endogenous mRNA decay 0.9
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.9
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 0.9
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 0.9
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.89
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.89
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.87
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.87
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 0.85
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.85
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.85
KSDM1b Role in Ewing Sarcoma 0.84
Identification of global XBP1s target gene expression in human prostate cancer cells 0.83
The pause-initiation limit restricts transcription activation in human cells 0.81
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.81
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.81
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.8
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.79
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.79
Triple vectors expand AAV transfer capacity in the retina 0.79
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.78
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.77
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.76
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.76
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.76
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 0.75
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.75
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.75
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.75
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 0.75
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.75
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.73
RNAseq analysis of ruxolitinib treated breast cancers 0.73
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 0.72
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.71
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.71
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.7
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.7
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.7
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.69
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.68
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.68
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.68
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.67
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.65
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.65
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.65
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 0.65
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 0.65
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.64
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.63
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.63
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.62
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.62
Anti-inflammatory effect of indoleacrylic acid (IA) 0.61
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.6
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.6
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.6
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.59
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.59
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.57
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.57
The contribution of Alu exons to the human proteome 0.57
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.57
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.56
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.56
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.55
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.55
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.54
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.53
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.53
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.53
An optimization system for isolating and sequencing of single human colon cancer cells 0.52
MicroRNA-125a-5p overexpression in human macrophages 0.52
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.51
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.51
RNA-seq data 0.51
RNA-seq of cells with TET1 knockout 0.49
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.49
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.49
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.49
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.49
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.49
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.48
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.48
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.48
The role of CFTR in islet function 0.47
RNA sequencing of T-ALL (COG study) 0.47
Analyses of T-ALL (COG study) 0.47
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.46
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.45
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.45
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.45
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.43
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.42
Total RNA-Seq data from leukemic patients with complex structural variants 0.42
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.41
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.39
HEK293 TFAM Knockout Expression Study 0.39
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.39
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.39
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.37
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.37
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.37
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.37
Aging-associated patterns in the expression of human endogenous retroviruses 0.36
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.35
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.34
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.34
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.34
A single-cell transcriptome atlas of the human pancreas 0.34
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.33
Determining mRNA half-lives on a transcriptome-wide scale 0.33
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.32
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.32
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.32
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.31
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.31
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.3
Microglia innatly develop within cerebral organoids 0.3
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.3
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.3
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.29
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.29
Transcriptional landscape changes during human embryonic stem cell derivation 0.29
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.28
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.28
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.27
Global transcriptome analysis of WT versus HEB-/- hESCs 0.27
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.26
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.26
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.24
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.24
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.24
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.24
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.24
Interphase condensins regulate ligand-depedent enhancer activation 0.23
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.23
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.22
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.22
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.21
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.19
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.18
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.18
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.17
Human Treg IFNg/IL-10 subpopulations 0.16
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.16
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.15
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.14
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.14
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.13
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.13
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.13
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.13
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.13
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.12
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.12
SNHG5 siRNA knock down in HCT116 cells 0.11
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.1
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.09
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.09
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.08
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.06
Human Tfh cell RNA bulk sequencing 0.06
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.06
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.06
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.06
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.06
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.05
MHC Transcriptomic landscape at haplotype-specific resolution 0.05
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.04
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.04
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.04
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.03
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.03
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.03
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.03
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.02
Leucegene: AML sequencing (part 6) 0.02
RNA-seq of primary patient AML samples 0.02
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation